| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Carbocisteine | Carbocisteine Lactam Impurity | VE009674 | View CAS 62305-89-9 |
| Carbocisteine | Carbocisteine Lactam Sodium Salt | VE006232 | View CAS 88933-48-6 |
| Carbocisteine | Carbocisteine Sulfoxide | VE006233 | View CAS 5439-87-2 |
| Carbocisteine | L-Lysine S-(Carboxymethyl)-L-Cysteine | VE009675 | View CAS 49673-81-6 |
| Carbocisteine | N, S-bis(Carboxymethyl)-L-cysteine | VE0010188 | View CAS 907565-13-3 |
| Carbocisteine | S-Carboximetilcisteine | VE007072 | View CAS 638-23-3 |
| Catalogue No. | VE009675 |
| CAS No. | 49673-81-6 |
| Molecular Formula | C11H23N3O6S |
| Molecular Weight | 325.38 g/mol |
| Parent drug | Carbocisteine |
| IUPAC Name | (R)-2-amino-3-((carboxymethyl)thio)propanoic acid compound with (S)-2, 6-diaminohexanoic acid (1:1) |
| Synonyms | Fluifort |
| References | Sci-Hub, Carbocisteine normalizes the viscous property of mucus through regulation of fucosylated and sialylated sugar chain on airway mucins. European Journal of Pharmacology, 641(2-3), 226–228, 10.1016/j.ejphar.2010.05.045. (2022). Retrieved August 7, 2022, from Sci-hub.se website: https://sci-hub.se/https://doi.org/10.1016/j.ejphar.2010.05.045 |
| Status | In-stock |
| ListName | L-Lysine S-(Carboxymethyl)-L-Cysteine |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
